Cargando…
Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation
BACKGROUND: Vessels that encapsulate tumor clusters (VETC) is a novel vascular pattern seen on hepatocellular carcinoma (HCC) histology which has been shown to independently predict tumor recurrence and survival after liver resection. Its prognostic value in HCC patients receiving liver transplantat...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643778/ https://www.ncbi.nlm.nih.gov/pubmed/36387254 http://dx.doi.org/10.3389/fonc.2022.997093 |
_version_ | 1784826592986398720 |
---|---|
author | Dennis, Claude Prince, David S. Moayed-Alaei, Leila Remash, Devika Carr-Boyd, Emily Bowen, David G. Strasser, Simone I. Crawford, Michael Pulitano, Carlo Kench, James McCaughan, Geoffrey W. McKenzie, Catriona Liu, Ken |
author_facet | Dennis, Claude Prince, David S. Moayed-Alaei, Leila Remash, Devika Carr-Boyd, Emily Bowen, David G. Strasser, Simone I. Crawford, Michael Pulitano, Carlo Kench, James McCaughan, Geoffrey W. McKenzie, Catriona Liu, Ken |
author_sort | Dennis, Claude |
collection | PubMed |
description | BACKGROUND: Vessels that encapsulate tumor clusters (VETC) is a novel vascular pattern seen on hepatocellular carcinoma (HCC) histology which has been shown to independently predict tumor recurrence and survival after liver resection. Its prognostic value in HCC patients receiving liver transplantation (LT) is unclear. METHODS: We retrospectively studied consecutive adults who underwent deceased-donor LT with active HCC found on explant between 2010-2019. Tumor tissue was stained for CD34 and quantified for VETC. Primary and secondary endpoints were time to recurrence (TTR) and recurrence-free survival (RFS). RESULTS: During the study period, 158 patients received LT where HCC was present on explant. VETC pattern was seen in 76.5% of explants. Patients with VETC-positive tumors spent longer on the waitlist (6.4 vs. 4.1 months, P=0.048), had higher median tumor numbers (2 vs. 1, P=0.001) and larger tumor sizes (20mm vs. 13mm, P<0.001) on explant pathology compared to those with VETC-negative tumors. Correspondingly, VETC-positive patients were more likely to be outside of accepted LT criteria for HCC. After 56.4 months median follow-up, 8.2% of patients developed HCC recurrence post-LT. On multivariable Cox regression, presence of VETC pattern did not predict TTR or RFS. However, the number of VETC-positive tumors on explant was an independent predictor of TTR (hazard ratio [HR] 1.411, P=0.001) and RFS (HR 1.267, P=0.014) after adjusting for other significant variables. CONCLUSION: VETC pattern is commonly observed in HCC patients undergoing LT. The number of VETC-positive tumors, but not its presence, is an independent risk factor for TTR and RFS post-LT. |
format | Online Article Text |
id | pubmed-9643778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96437782022-11-15 Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation Dennis, Claude Prince, David S. Moayed-Alaei, Leila Remash, Devika Carr-Boyd, Emily Bowen, David G. Strasser, Simone I. Crawford, Michael Pulitano, Carlo Kench, James McCaughan, Geoffrey W. McKenzie, Catriona Liu, Ken Front Oncol Oncology BACKGROUND: Vessels that encapsulate tumor clusters (VETC) is a novel vascular pattern seen on hepatocellular carcinoma (HCC) histology which has been shown to independently predict tumor recurrence and survival after liver resection. Its prognostic value in HCC patients receiving liver transplantation (LT) is unclear. METHODS: We retrospectively studied consecutive adults who underwent deceased-donor LT with active HCC found on explant between 2010-2019. Tumor tissue was stained for CD34 and quantified for VETC. Primary and secondary endpoints were time to recurrence (TTR) and recurrence-free survival (RFS). RESULTS: During the study period, 158 patients received LT where HCC was present on explant. VETC pattern was seen in 76.5% of explants. Patients with VETC-positive tumors spent longer on the waitlist (6.4 vs. 4.1 months, P=0.048), had higher median tumor numbers (2 vs. 1, P=0.001) and larger tumor sizes (20mm vs. 13mm, P<0.001) on explant pathology compared to those with VETC-negative tumors. Correspondingly, VETC-positive patients were more likely to be outside of accepted LT criteria for HCC. After 56.4 months median follow-up, 8.2% of patients developed HCC recurrence post-LT. On multivariable Cox regression, presence of VETC pattern did not predict TTR or RFS. However, the number of VETC-positive tumors on explant was an independent predictor of TTR (hazard ratio [HR] 1.411, P=0.001) and RFS (HR 1.267, P=0.014) after adjusting for other significant variables. CONCLUSION: VETC pattern is commonly observed in HCC patients undergoing LT. The number of VETC-positive tumors, but not its presence, is an independent risk factor for TTR and RFS post-LT. Frontiers Media S.A. 2022-10-26 /pmc/articles/PMC9643778/ /pubmed/36387254 http://dx.doi.org/10.3389/fonc.2022.997093 Text en Copyright © 2022 Dennis, Prince, Moayed-Alaei, Remash, Carr-Boyd, Bowen, Strasser, Crawford, Pulitano, Kench, McCaughan, McKenzie and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Dennis, Claude Prince, David S. Moayed-Alaei, Leila Remash, Devika Carr-Boyd, Emily Bowen, David G. Strasser, Simone I. Crawford, Michael Pulitano, Carlo Kench, James McCaughan, Geoffrey W. McKenzie, Catriona Liu, Ken Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation |
title | Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation |
title_full | Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation |
title_fullStr | Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation |
title_full_unstemmed | Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation |
title_short | Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation |
title_sort | association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643778/ https://www.ncbi.nlm.nih.gov/pubmed/36387254 http://dx.doi.org/10.3389/fonc.2022.997093 |
work_keys_str_mv | AT dennisclaude associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT princedavids associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT moayedalaeileila associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT remashdevika associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT carrboydemily associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT bowendavidg associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT strassersimonei associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT crawfordmichael associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT pulitanocarlo associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT kenchjames associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT mccaughangeoffreyw associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT mckenziecatriona associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation AT liuken associationbetweenvesselsthatencapsulatetumourclustersvascularpatternandhepatocellularcarcinomarecurrencefollowinglivertransplantation |